Aldeyra Therapeutics (ALDX) Financial Statements

Aldeyra Therapeutics's market cap is currently $317.66M. The company's EPS TTM is $; its P/E ratio is -7.32; Aldeyra Therapeutics is scheduled to report earnings on May 6, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.